Novel Cord Blood Stem Cell Treatment Leads to HIV Remission
Cord blood stem cell transplant shows promise to long-term HIV remission, offering hope for a potential cure. Could this breakthrough change the future of HIV treatment?
Umbilical Cord Stem Cells Show Promise for Bell’s Palsy Treatment
A case of recovery after seven years of facial paralysis
Stem Cell Transplantation Shows Potential in Stroke Recovery
A medical case study demonstrates the potential of stem cell therapy to treat acute ischemic stroke, offering new hope for patients facing long-term disability
Mesenchymal Stem Cell Therapy for Psoriasis: A New Treatment Approach
A 47-year-old man with 25 years of psoriasis finds relief through an new treatment using umbilical cord stem cells.
Transplant of patients’ own stem cells improves survival in older adults with multiple myeloma
A study from the journal of Bone Marrow Transplantation shows that older multiple myeloma patients who received a transplant of their own stem cells following chemotherapy survived significantly longer than patients who received the standard treatment of chemotherapy alone.
Bankability: Factors that influence the preservation of your baby’s cord blood
This study looks at factors that can influence cord blood usability to increase the likelihood of banking.
Study to look at using umbilical cord stem cells to tackle brain damage
We are highlighting the latest development in newborn stem cell research, where a group of scientists from around the world are exploring the potential of cord tissue stem cells to tackle brain damage in preterm babies.
Non-invasive, intranasal administration of umbilical cord stem cells can restore damage caused by lung disease
Preclinical studies show that umbilical cord stem cells can effectively restore damage from chronic lung disease.
Cell-free therapy using cord tissue stem cells for treating Alzheimer’s disease
Scientists explore the potential of using cord tissue mesenchymal stem cell extracts to slow Alzheimer’s disease progression.
Stem cells as antimicrobials?
Mesenchymal stem cells release antimicrobial factors that enhance the activity of traditional antibiotics.
Umbilical cord stem cells enhance the survival rates in critically ill COVID-19 patients
According to a small clinical trial, patients on ventilators due to COVID-19 are 2.5 times more likely to recover following umbilical cord stem cell treatment.
Clinical trials investigate the use of stem cell therapy for treating COVID-19
Will we be able to curb this pandemic effectively? Will the solution be a vaccine, an anti-viral, stem cell therapy, or perhaps a combination of all?
Extending stem cell compatibility with antibodies
Donor compatibility is one of the biggest bottlenecks associated with hematopoietic stem cell transplants.
Viruses, immunity and stem cells
Explore the link between infections, immunity, and stem cells in this blog post.
Stem cell therapy to battle lung disease
First-in-human clinical trials reveals the potential of using mesenchymal stem cells to slow the rapid decline of lung function associated with pulmonary fibrosis.
The umbilical cord can be a long-term source for mesenchymal stem cells
This study highlights the umbilical cord can be used to produce mesenchymal stromal cells (MSCs) in the long-term, which will drastically increase the availability of MSCs for therapeutic use.
